Pancytopenia After Allopurinol Joined the IBD Regimen
Pancytopenia After Allopurinol Joined the IBD Regimen - Clinical Pharmacology clinical simulation case. 47-year-old male with Crohn disease on...
Age: 47 • Gender: Male • Setting: Emergency Triage
Clinical Presentation & History
47-year-old male with Crohn disease on azathioprine, recently started on allopurinol for gout, presenting with fever, oral ulceration, and severe neutropenia. 47-year-old male with a ten-year history of ileal Crohn disease maintained on azathioprine 150 mg daily, presenting after three weeks of allopurinol 300 mg daily for new-onset gout.
Acute Resuscitation Milestones & Priorities
Clinical phases and key interventions encountered in this emergency module:
Initial Triage & Septic Presentation
Severe Neutropenia Confirmed & Antifungal Decisions
Reconstructing the Pharmacology & TPMT Status
Gout Management & Safe Discharge Planning
High-Yield Clinical Pearls
Allopurinol inhibits xanthine oxidase, the enzyme that clears 6-mercaptopurine to inactive 6-methylmercaptopurine; co-administration shunts metabolism toward cytotoxic 6-TGNs, causing life-threatening pancytopenia.
TPMT intermediate activity is a yellow flag — concurrent XO inhibition is the lethal pairing; 6-TGN levels > 1000 pmol/8×10⁸ RBC correlate with grade 3-4 neutropenia.
Severe neutropenia (ANC < 0.1) with persistent fever mandates empiric antifungal coverage per IDSA, plus filgrastim to accelerate marrow recovery.
After life-threatening thiopurine myelosuppression, rechallenge is contraindicated; transition to a biologic such as an anti-integrin (vedolizumab) bypasses TPMT metabolism entirely.
Document permanent pharmacy interaction alerts and a thiopurine contraindication flag in the medical record to prevent fatal recurrence at subsequent visits.
Test Your Clinical Reasoning in Real Time
Step into the active clinician role for this case. Order diagnostic tests, analyze live laboratory panels, and navigate branching clinical decisions with real-time feedback.